About Us

Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

A Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Social Media

Bluesky • Facebook • Instagram • LinkedIn • YouTube

Meet the Laser Focus World Team

Editorial

Sales

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology
My Watchlist
Indicators
Industrial Laser Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ZEN Graphene Solutions and Trebor RX Announce Successful Inhalation Safety Testing of ZENGuard(TM)-Enhanced Surgical Masks and Final Submission to Health Canada

By: via AccessWire

GUELPH, ON / ACCESSWIRE / June 4, 2021 / ZEN Graphene Solutions Ltd. ("ZEN" or the "Company") (TSXV:ZEN)(OTC PINK:ZENYF), a Canadian, next-gen nanomaterials technology company and Trebor Rx Corp. (Trebor) are pleased to announce successful inhalation safety testing results of ZENGuardTM-enhanced surgical masks and submission of these results to Health Canada. Testing was completed by NanoSafe Inc. (NanoSafe) in Blacksburg, Virginia confirmed that no ZENGuardTM graphene material was released from the surgical masks with air flow rates simulating resting and light activity inhalation rates. The test results submitted to Health Canada are the final item from the information request ZEN received following the April 2 advisory. Health Canada is reviewing the application as a priority item with a decision expected shortly.

Greg Fenton, ZEN CEO commented: "With the final piece of safety information submitted to Health Canada, we believe our ZENGuardTM-enhanced PPE is poised to become a commercial reality and bring an added level of protection to those that need it most. We remain fully aligned with Health Canada on the need to protect Canadians and value the opportunity to proactively differentiate our product from others in the market. ZEN is focused on developing and commercializing nanotechnologies that help protect people - and we expect our highly-effective, Made-in-Canada solution to do just that."

Inhalation Testing Details

Testing was completed by NanoSafe - a company based in the Virginia Tech Corporate Research Center focused on taking a discipled and rational scientific approach to understanding environmental, health and safety risks related to nanotechnology.

  • Testing was designed to evaluate particulate release to provide a maximum potential exposure of graphene-containing particles to mask wearers or bystanders in a typical use scenario

  • Seven coated and uncoated masks were tested with three iterations each measuring the average particulate concentration over one minute

  • Particulates released during testing were analyzed by scanning electron microscopy with energy-dispersive x-ray spectrometry

  • On average, airborne particulate concentrations measured during testing of ZENGuardTM coated masks were observed to be lower than those of uncoated masks

  • At a higher simulated inhalation rate, ZENGuardTM coated masks reduced the particulate concentration in comparison to the cleanroom background, providing further filtration of the cleanroom air

  • No ZENGuardTM coating was detected in the limited amount of released particulate

For further information: 
Greg Fenton, Chief Executive Officer 
Tel: 1(437) 220-8140 
Email: gfenton@zengraphene.com 

About ZEN Graphene Solutions Ltd.

ZEN is a next-gen nanomaterials technology company developing graphene-based technologies that help protect people and the environment. ZEN is currently focused on commercializing ZENGuardTM, a patent pending graphene-based coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar graphene compounds as pharmaceutical products against infectious diseases. The company has a significant R&D pipeline with an interest in monomers, polymers, metal alloys, corrosion coatings, biosensors along with the production of graphene oxide and graphene quantum dots.  Additionally, the company owns the unique Albany Graphite Project which provides the company with a potential competitive advantage in the graphene market. Labs in Japan, UK, Israel, USA, and Canada have independently demonstrated that ZEN's Albany PureTM Graphite is an ideal precursor material that easily converts (exfoliates) to graphene, using a variety of mechanical, chemical, and electrochemical methods.

About Trebor Rx Corp.

Trebor Rx Corp. is led by George Irwin and Brenda Elliott, the 3rd generation Canadian business icons behind the Irwin Toy brand, which has been operating in Canada for almost 100 years. Fueled by a dedicated and compassionate team prioritizing safety and innovation, Trebor is disrupting the PPE industry and setting a new standard of production for masks and face shields while solving problems of cost, comfort, and medical waste. A proudly Canadian company with a production facility located in Collingwood, Ontario, Trebor is committed to providing Healthcare, Frontline, and Essential workers with innovative, new patented technology PPE during COVID-19 and beyond.

To find out more about ZEN Graphene Solutions Ltd., please visit our website at www.ZENGraphene.com. A copy of this news release and all material documents in respect of the Company may be obtained on ZEN's SEDAR profile at www.sedar.ca. 

Forward-Looking Statements 

This news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although ZEN believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. ZEN disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. 

SOURCE: ZEN Graphene Solutions Ltd.



View source version on accesswire.com:
https://www.accesswire.com/650441/ZEN-GrapheneSolutionsand-Trebor-RX-Announce-Successful-Inhalation-Safety-Testing-of-ZENGuardTM-Enhanced-Surgical-Masks-and-Final-Submission-to-Health-Canada

More News

View More
Marvell Insiders Buy Shares—Should Investors Follow Suit?
Via MarketBeat
Topics Artificial Intelligence
Tickers MRVL NVDA ORCL
Trump’s Drug Price Cuts: Boom or Bust for These 3 Pharma Giants
Via MarketBeat
Topics Government Supply Chain World Trade
Tickers JNJ LLY PFE
3 Fintech Stocks That Are Set to Rise as Rates Fall
Via MarketBeat
Topics Economy
Tickers AFRM RKT UPST
Cleveland-Cliffs Rally Tops S&P 500, Can It Continue?
Via MarketBeat
Topics Government Stocks World Trade
Tickers CLF
3 Travel Stocks to Watch Heading Into the Holidays
Via MarketBeat
Tickers EXPE LUV RCL
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.